Application Notes & Case Studies
-
EHR-To-EDC Success In A Complex, Adaptive Platform Trial
4/17/2025
I-SPY 2, one of the longest-running adaptive platform trials in oncology, is revolutionizing breast cancer research through a dynamic, data-driven approach to evaluating novel therapies.
-
Unlocking Recruitment Potential In Trial-Naïve Sites
4/17/2025
Site Professional Support enabled this late-phase rheumatoid arthritis study to conduct complex patient visits despite it's use of sites that lacked research experience and resources.
-
Delivering Specialist Neurology Support
4/17/2025
Explore a strategic approach to a Parkinson’s disease trial that leveraged a global infrastructure and multilingual workforce to provide seamless operational and clinical support.
-
Enhance Access And Improve Retention In Rare Disease Trials With HTS
4/17/2025
Home Trial Support (HTS) provides a solution to improving participant recruitment and retention during musculoskeletal studies.
-
Accelerating Early Phase Oncology Study Development
4/17/2025
Explore a close collaboration to co-develop a comprehensive, adaptive protocol designed to support key decisions across multiple trial phases for an innovative cancer therapy.
-
Advancing Immunotherapy In Head And Neck Cancer: The IT-MATTERS Study
4/17/2025
This randomized controlled pivotal phase 3 study evaluated efficacy and safety of neoadjuvant complex biologic administered for 3 consecutive weeks pre-surgery.
-
Feasibility Insights In HR+/HER2 - Metastatic Breast Cancer
4/16/2025
This case study showcases system that streamline feasibility planning using advanced analytics for a Phase II clinical trial targeting HR+/HER2- metastatic breast cancer as a second-line treatment.
-
Pioneering The End-To-End Decentralized Trial Experience
4/16/2025
Explore a collaboration between a top 20 pharmaceutical company and Medidata that highlights the potential of DCTs to transform trial execution, offering a replicable model for future research.
-
Accelerate Your Oncology Breakthroughs
4/16/2025
Finding the right partnership can help your oncology clinical trials overcome trial complexities through strategic planning, a deep scientific understanding, and operational excellence.
-
Digital Outcome Measures Approved As Primary Endpoint In Cardiopulmonary Study
4/15/2025
Discover how a clinical development program was saved using objective, continuous digital outcome measures.